MaxCyte, Inc. (NasdaqGS: MXCT)
Health Care · Life Sciences Tools & Services · US
$1.38
+4.55% today · -2.8% 1Y
MaxCyte, Inc. (NasdaqGS: MXCT) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $142.42M and employs 91 people.
Over the last twelve months the share price has lost 2.8%, trading between 0.64 and 1.87.
Tweenvest scores MaxCyte, Inc. across four factors: quality 42/100, value 53/100, growth 0/100. Its strongest factor is value.
MXCT price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $142.42M
- Revenue (TTM)
- $31.05M
- P/E
- —
- EPS
- -0.33
- Dividend yield
- —
- Beta (5Y)
- 1.49
- 52-week high
- $1.87
- 52-week low
- $0.64
- Avg volume (3M)
- —
- Shares outstanding
- 103.21M
- Employees
- 91
- Next earnings
- —
About MaxCyte, Inc.
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.
- ISIN
- US57777K1060
- Founded
- 1998
- Listed since
- Jul 29, 2021
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Thermo Fisher Scientific Inc.NYSE: TMO | $232.67B | $629.27 | +0.27% |
| Danaher CorporationNYSE: DHR | $153.85B | $218.85 | +1.36% |
| WuXi AppTec Co., Ltd.SHSE: 603259 | $72.12B | CN¥162.86 | -3.00% |
| Samsung Biologics Co.,Ltd.KOSE: A207940 | $51.75B | ₩1,551,000.00 | +0.19% |
| Lonza Group AGSWX: LONN | $51.61B | CHF590.20 | -0.34% |
| Agilent Technologies, Inc.NYSE: A | $44.91B | $159.00 | +1.73% |
| IQVIA Holdings Inc.NYSE: IQV | $42.77B | $259.82 | +1.47% |
| Waters CorporationNYSE: WAT | $40.35B | $410.70 | +1.49% |
Figures last refreshed Aug 18, 2026.